Brochure | July 8, 2022

CDMO R&D Innovation & Proprietary Platforms Improve Speed To Market And Quality For Protein Biologics


AGC Biologics, a global CDMO that harnesses its R&D centers to bring modern and efficient approaches to development and manufacturing. The company’s R&D centers work alongside its teams at its seven global sites to create strategies and procedures that emphasize quality product delivery.

Through the work of its research and development scientists AGC Biologics is creating innovations and offering the latest technology for early and late stage clients, helping them focus on increasing mass, increased speed to market, and overall process intensification.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma